Pharmacology and pharmacotherapy of cardiovascular drugs in patients with chronic renal disease

2001 ◽  
Vol 21 (1) ◽  
pp. 66-78 ◽  
Author(s):  
Marilyn M. Barbour ◽  
David S. McKindley
1970 ◽  
Vol 126 (5) ◽  
pp. 774-780 ◽  
Author(s):  
A. J. Erslev

1971 ◽  
Author(s):  
Virgil Smirnow ◽  
Robert J. Shaloub ◽  
Jonathan W. Cummings ◽  
Vincent Glaudin ◽  
Roy Brener ◽  
...  

2001 ◽  
Vol 11 (4) ◽  
pp. 183-193 ◽  
Author(s):  
Tedine Ranich ◽  
Sam J. Bhathena ◽  
Manuel T. Velasquez

2001 ◽  
Vol 21 (1) ◽  
pp. 3-12 ◽  
Author(s):  
Amin Al-Ahmad ◽  
Mark J. Sarnak ◽  
Deeb N. Salem ◽  
Marvin A. Konstam

1980 ◽  
Vol 19 (04) ◽  
pp. 205-209
Author(s):  
L. A. Abbott ◽  
J. B. Mitton

Data taken from the blood of 262 patients diagnosed for malabsorption, elective cholecystectomy, acute cholecystitis, infectious hepatitis, liver cirrhosis, or chronic renal disease were analyzed with three numerical taxonomy (NT) methods : cluster analysis, principal components analysis, and discriminant function analysis. Principal components analysis revealed discrete clusters of patients suffering from chronic renal disease, liver cirrhosis, and infectious hepatitis, which could be displayed by NT clustering as well as by plotting, but other disease groups were poorly defined. Sharper resolution of the same disease groups was attained by discriminant function analysis.


1951 ◽  
Vol 8 (2) ◽  
pp. 165-174
Author(s):  
SVEN JOHNSSON ◽  
ROLF LUFT ◽  
BJÖRN SJÖGREN ◽  
JAN WALDENSTRÖM

2008 ◽  
Vol 149 (15) ◽  
pp. 691-696
Author(s):  
Dániel Bereczki

Chronic kidney diseases and cardiovascular diseases have several common risk factors like hypertension and diabetes. In chronic renal disease stroke risk is several times higher than in the average population. The combination of classical risk factors and those characteristic of chronic kidney disease might explain this increased risk. Among acute cerebrovascular diseases intracerebral hemorrhages are more frequent than in those with normal kidney function. The outcome of stroke is worse in chronic kidney disease. The treatment of stroke (thrombolysis, antiplatelet and anticoagulant treatment, statins, etc.) is an area of clinical research in this patient group. There are no reliable data on the application of thrombolysis in acute stroke in patients with chronic renal disease. Aspirin might be administered. Carefulness, individual considerations and lower doses might be appropriate when using other treatments. The condition of the kidney as well as other associated diseases should be considered during administration of antihypertensive and lipid lowering medications.


2018 ◽  
Vol 7 (2) ◽  
pp. 72
Author(s):  
Cristiano Batista Gonçalves

Objetivo: analisar a produção científica nacional e internacional sobre tecnologias educativas voltadas à promoção da saúde do paciente com doença renal crônica. Metodologia: trata-se de uma revisão integrativa da literatura; utilizou-se a questão norteadora: Quais as evidências disponíveis na literatura científica sobre tecnologias educativas voltadas à promoção da saúde do paciente com doença renal crônica?; não houve imposição de limite de tempo, e utilizou-se as bases de dados SciELO, MEDLINE, LILACS e CINAHL, com cruzamento dos seguintes descritores: renal insufficiency, educational technology, health promotion. Resultados: incluíram-se seis estudos nesta revisão e elencou-se quatro categorias sobre as tecnologias educativas: software para computador ou dispositivo móvel, material impresso, programa educacional via telefone e website. Conclusão: diferentes tecnologias educativas construídas evidenciam a preocupação dos profissionais da saúde em promover a longitudinalidade do cuidado e integralidade da saúde aos indivíduos com doença renal crônica, como também lhes instiga a tornarem-se protagonistas no cuidado da sua saúde.Descritores: Insuficiência Renal Crônica. Tecnologia Educacional. Promoção da Saúde.


Sign in / Sign up

Export Citation Format

Share Document